GWM
ABBV icon

Greenwich Wealth Management’s AbbVie ABBV Stock Holding History

Greenwich Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Buy
14,267
+36
+0.3% +$7.75K 0.13% 85
2026
Q1 		$3.1M Buy
14,231
+17
+0.1% +$3.77K 0.13% 90
2025
Q4 		$3.25M Buy
14,214
+168
+1% +$38.3K 0.14% 84
2025
Q3 		$3.25M Buy
14,046
+2
+0% +$407 0.16% 79
2025
Q2 		$2.61M Buy
14,044
+4
+0% +$743 0.13% 75
2025
Q1 		$2.94M Sell
14,040
-206
-1% -$40K 0.22% 58
2024
Q4 		$2.53M Buy
14,246
+24
+0.2% +$4.41K 0.18% 64
2024
Q3 		$2.81M Buy
14,222
+34
+0.2% +$6.35K 0.19% 64
2024
Q2 		$2.43M Sell
14,188
-6
-0% -$994 0.18% 67
2024
Q1 		$2.58M Buy
14,194
+116
+0.8% +$20K 0.21% 65
2023
Q4 		$2.18M Sell
14,078
-82
-0.6% -$12K 0.22% 66
2023
Q3 		$2.11M Buy
14,160
+994
+8% +$146K 0.22% 59
2023
Q2 		$1.77M Sell
13,166
-189
-1% -$27.7K 0.19% 77
2023
Q1 		$2.13M Buy
13,355
+42
+0.3% +$6.42K 0.23% 66
2022
Q4 		$2.15M Buy
13,313
+397
+3% +$60.9K 0.24% 66
2022
Q3 		$1.73M Sell
12,916
-703
-5% -$101K 0.18% 78
2022
Q2 		$2.09M Buy
13,619
+703
+5% +$107K 0.28% 65
2022
Q1 		$2.09M Sell
12,916
-28
-0.2% -$4.07K 0.21% 74
2021
Q4 		$1.75M Buy
12,944
+19
+0.1% +$2.24K 0.14% 81
2021
Q3 		$1.39M Buy
12,925
+1,010
+8% +$115K 0.12% 90
2021
Q2 		$1.34M Sell
11,915
-870
-7% -$98K 0.11% 90
2021
Q1 		$1.38M Buy
12,785
+362
+3% +$38.7K 0.11% 88
2020
Q4 		$1.33M Buy
12,423
+531
+4% +$51K 0.12% 82
2020
Q3 		$1.04M Buy
11,892
+5
+0% +$471 0.19% 85
2020
Q2 		$1.17M Buy
11,887
+222
+2% +$19.5K 0.22% 78
2020
Q1 		$889K Buy
+11,665
New +$994K 0.19% 77

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Greenwich Wealth Management's ABBV Position: Q2 2026 in Review

Greenwich Wealth Management increased its AbbVie (ABBV) stake by 0.25% in Q2 2026, buying an estimated $7.75K and bringing the position to 14,267 shares worth $3.59M. The position accounts for 0.13% of the portfolio, ranked #85.

Greenwich Wealth Management first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Greenwich Wealth Management held 14,267 shares of AbbVie worth $3.59M as of Q2 2026.
  • Greenwich Wealth Management bought 36 AbbVie shares in Q2 2026, an estimated $7.75K.
  • AbbVie made up 0.13% of Greenwich Wealth Management's portfolio in Q2 2026, its #85 holding.
  • Greenwich Wealth Management first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Greenwich Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.